3-hydroxy-6-methyl-2-pyridinecarbaldehyde, 95.0%, 250mg

(1-Hydroxy-cyclohexyl)-acetic acid, 95.0%, 1g

(R)-5,5-Diphenyl-2-methyl-3,4-propano-1,3,2-oxazaborolidine>97.0%(T)1g

Methyl DL-2-(1-Boc-piperidin-4-yl)-beta-glycinate, 97.0%, 100mg

2-{3-hydroxy-1H-cyclopenta[b]naphthalen-1-ylidene}propanedinitrile, 97%, 250mg

2-([1,1'-biphenyl]-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

Ethyl 2-chloro-6-methylisonicotinate, 95.0%, 25g

1-(Cyclohexyloxy)-4-fluoro-2-nitrobenzen, 95.0%, 1g

N-((1R,2R)-2-Amino-1,2-diphenylethyl)-4-(trifluoromethyl)benzenesulfonamide, 97%, 1g

Diethanolamin, min. 99 %, zur Synthese, 5 l, kunststoffverpackung.

1,11-Dibromoundecane, 96%, 5g

3-(2-Chloro-5-(trifluoromethyl)pyrimidin-4-yl)-1H-indole, 97%, 10g

((2R,3R,4S,5R)-3-(Benzoyloxy)-5-bromo-4-fluorotetrahydrofuran-2-yl)methyl benzoate, 97%, 250mg